SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Yen TSB. Hepadnaviral X protein: Review of recent progress. J. Biomed. Sci. 1996; 3: 20 30.
  • 2
    Rossner MT. Hepatitis B virus X-gene product: A promiscuous transcriptional activator. J. Med. Virol. 1992; 36: 101 17.
  • 3
    Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 1994; 68: 2026 30.
  • 4
    Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317 20.
  • 5
    Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 1996; 15: 261 9.
  • 6
    Arbuthnot P, Capovilla A, Kew M. Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathway. J. Gastroenterol. Hepatol. 2000; 15: 357 68.
  • 7
    Heller RA & Kronke M. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell. Biol. 1994; 126: 5 9.
  • 8
    Bates S & Vousden KH. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 1996; 6: 12 18.
  • 9
    Wagner AJ, Kokontis JM, Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 1994; 8: 2817 30.
  • 10
    Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220 3.
  • 11
    Wang XW, Gibson MK, Vermeulen W et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 1995; 55: 6012 16.
  • 12
    Terradillos O, Pollicino T, Lecoeur H et al. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17: 2115 23.
  • 13
    Su F & Schneider RJ. Hepatitis B virus HBx protein sensitized cells to apoptotic killing by tumor necrosis factor-α. Proc. Natl Acad. Sci. USA 1997; 94: 8744 9.
  • 14
    Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 1998; 273: 33 347 53.
  • 15
    Feitelson MA, Zhu M, Duan L-X, London WT. Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993; 8: 1109 17.
  • 16
    Ueda H, Ullrich SJ, Gangemi JD et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet. 1995; 9: 41 7.
  • 17
    Reed M, Woelker B, Wang P, Wang Y, Anderson ME, Tegtmeyer P. The C-terminal domain of p53 recognises DNA damaged by ionising radiation. Proc. Natl Acad. Sci. USA 1995; 92: 9455 9.
  • 18
    Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res. 1997; 57: 5137 42.
  • 19
    Feaver WJ, Svejstrup JQ, Henry NL, Kornberg RD. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 1994; 79: 1103 9.
  • 20
    Aboussekhra A, Biggerstaff M, Shivji MKK et al. Mammalian DNA nucleotide excision repair reconstituted with purified components. Cell 1995; 80: 859 68.
  • 21
    Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc. Natl Acad. Sci. USA 1996; 93: 10 578 83.
  • 22
    Becker SA, Lee T, Butel JS, Slagle BL. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 1998; 72: 266 72.
  • 23
    Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 1993; 268: 14 553 6.
  • 24
    Klein NP & Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol. Cell. Biol. 1997; 17: 6427 36.
  • 25
    Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway. Nature 1993; 361: 742 5.
  • 26
    Henkler F, Lopes AR, Jones M, Koshy R. Erk-independent partial activation of AP-1 sites by the hepatitis B virus HBx protein. J. Gen. Virol. 1998; 79: 2737 42.
  • 27
    Ransohoff RM. Cellular responses to interferons and other cytokines: The JAK-STAT paradigm. N. Engl. J. Med. 1998; 338: 616 18.
  • 28
    Lee Y-H & Yun Y. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J. Biol. Chem. 1998; 273: 25 510 15.
  • 29
    Su Q, Schröder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinoma. Hepatology 1998; 27: 1109 20.